Building on the success of its direct-to-consumer COVID-19 testing options, Labcorp has established a new platform that allows it to sidestep healthcare provider middlemen and enable individuals to ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced the appointments of Prasanth Reddy, MD, MPH, and Robert Phillips, PhD, to its oncology ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced the appointment of Glenn A. Eisenberg as Executive Vice President and Chief ...
BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp® (NYSE: LH), a leading global life sciences company, today announced a significant expansion to its Pixel by LabCorp™ platform. The new offering allows ...
Labcorp Holdings, Inc. LH has announced the nationwide availability of the Lumipulse pTau-217/Beta Amyloid 42 Ratio — the first FDA-cleared blood-based in-vitro diagnostic (IVD) test to assist in ...
Laboratory Corporation of America Holdings LH or LabCorp inked a strategic collaboration deal with Ascension – a U.S.-based Catholic and non-profit health system to expand patient access to LabCorp’s ...